ALSFAC-Funded Project Announces Successful ALS Clinical Trial and High-Profile PublicationIn The Media

Amylyx, a start-up biotech company developing new treatments for ALS supported by ALS Finding a Cure®, and Mass General Hospital, announced the publication of results from its successful pivotal stage ALS clinical trial in the prestigious New England Journal of Medicine (NEJM).
Amylyx Timeline

ALSFAC Funded Research Turns Off Key Gene in Families with ALS In The Media

Researchers at the University of Massachusetts Medical School and Massachusetts General Hospital report progress on a potential new weapon against the fatal nerve disease ALS.
Report Progress

ALS Drug Works in Study, Researchers Say in the MediaIn The Media

If promising data hold up, Amylyx Pharmaceuticals' drug could lead a wave of treatments for Lou Gehrig's disease
Read More
Load More

A Program Of

Advisory Board

  • Leandro P. Rizzuto
  • Peter N. Foss
  • Merit  Cudkowicz, MD
  • Denis  Rizzuto
  • Stanley H. Appel, MD
  • Robert  Brown, D.Phil., MD
  • Tom  Gentile
  • Clive  Svendsen, PhD
  • Richard  Ellenbogen, MD
  • Randy  Fishman
  • Edward J. Rapp
  • Luca  Marinelli, PhD